Clinical Updates in the Management of Genito Urinary | Welcome & Introduction

Screening and Pre - operative Biomarkers in Prostate Cancer

Prostate Cancer - Oligometastastatic-Grey zone - Metastatic or Non metastatic

Progress in Prostate Cancer A Focus on PARP Inhibitors

Role of Darolutamide in nmCRPC

Panel discussion | Genetic testing in prostate cancer and management of mCRPC

Factors to Considewr While Choosing First Line Therapy-Immunotherapy

Advanced RCC-Personalizing Treatment in the ERA of Immunotherapy

Consistency in Efficacy of Pazopanib across Clinical Trials and Real World Setting

Case Based Panel Discussion | RCC

Clinical Updates in the Management of Genito Urinary | Closing Remarks